ACADIA Pharmaceuticals Inc.'s low P/S ratio is due to its po...
ACADIA Pharmaceuticals Inc.'s low P/S ratio is due to its poor revenue outlook. Investors' gloomy expectations for future revenue growth are driving the low P/S ratio. These conditions will persist as a hurdle for the share price unless improved.
Lacklustre Performance Is Driving ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Low P/S
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment